Aetna modified CPB 0816 for hand transplantation and multi-digit allotransplantation, effective December 4, 2025. Both procedures remain non-covered under the Aetna hand transplantation coverage policy — here's what that means for your billing team right now.
Aetna, a CVS Health company, classifies hand transplantation and multi-digit allotransplantation for metacarpal hand reconstruction as experimental, investigational, or unproven. CPB 0816 Aetna governs this determination, and the December 4, 2025 update keeps that classification firmly in place. The ICD-10-CM codes spanning traumatic amputation of the upper extremity — S48.011 through S68.729 — are the diagnosis codes most likely to appear on claims touching this policy. If your practice or facility bills for upper extremity reconstruction, this update deserves your attention before claims go out the door.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Aetna, a CVS Health company |
| Policy | Hand Transplantation — CPB 0816 |
| Policy Code | CPB 0816 |
| Change Type | Modified |
| Effective Date | December 4, 2025 |
| Impact Level | High |
| Specialties Affected | Hand surgery, plastic and reconstructive surgery, orthopedic surgery, transplant surgery |
| Key Action | Flag any claims involving hand or multi-digit transplantation for denial management before submission — Aetna will not reimburse these procedures |
Aetna Hand Transplantation Coverage Criteria and Medical Necessity Requirements 2025
The short answer on Aetna hand transplantation coverage criteria: there are none. Aetna does not cover hand transplantation or multi-digit allotransplantation under any clinical circumstances. The coverage policy classifies both as experimental, investigational, or unproven. No set of medical necessity criteria unlocks coverage.
That distinction matters enormously for billing teams. When a payer lists coverage criteria, you can document against those criteria and build a prior authorization case. When a payer calls something experimental, the door is closed. No amount of supporting documentation, clinical notes, or prior authorization requests changes the outcome.
The medical necessity question here is not "does this patient meet criteria?" It is "have you told this patient and their surgeon that Aetna will not reimburse this procedure?" That conversation needs to happen before the surgery is scheduled, not after the claim comes back denied.
If your patient has Aetna coverage and their surgeon is planning a hand transplant or multi-digit reconstruction on a metacarpal hand, document the financial counseling conversation. Get a signed ABN or equivalent patient acknowledgment. This is your protection when the claim denial arrives.
Aetna Hand Transplantation Exclusions and Non-Covered Indications
CPB 0816 is, effectively, an exclusion policy. Both procedures it addresses are non-covered in their entirety.
Hand transplantation is considered experimental and investigational by Aetna. The policy cites insufficient evidence of effectiveness as the basis. This applies regardless of the patient's diagnosis, the extent of amputation, or the clinical rationale the treating surgeon provides.
Multi-digit allotransplantation for reconstruction of the metacarpal hand carries the same designation. The metacarpal hand — a hand that has lost all fingers but retains a functional palm — is sometimes reconstructed through toe-to-hand or allotransplantation techniques. Aetna draws a hard line here. Allotransplantation for this indication is not covered.
The real issue for billing teams is that these are high-cost, complex cases. When a claim for a procedure like this hits a payer wall, the dollar exposure is significant. Claim denial on a transplant case is not a $200 problem. Prepare accordingly.
Aetna's related policy CPB 0399 covers upper limb prostheses. If your patient is ultimately fitted with a prosthetic following amputation, that's the policy governing Aetna reimbursement for that path. Upper limb prostheses billing guidelines under CPB 0399 are a separate track — and a covered one.
Coverage Indications at a Glance
| Indication | Status | Relevant ICD-10 Codes | Notes |
|---|---|---|---|
| Hand transplantation (any indication) | Not Covered — Experimental | S68.011–S68.729 | Aetna considers insufficient evidence of effectiveness; prior authorization will not unlock coverage |
| Multi-digit allotransplantation for metacarpal hand reconstruction | Not Covered — Experimental | S68.011–S68.729 | Applies regardless of surgical rationale or clinical documentation |
| Upper extremity traumatic amputation (diagnosis coding) | Diagnosis codes only — not a covered procedure pathway | S48.011–S68.729 | Use for diagnosis coding on related claims; procedure coverage determined separately |
| Upper limb prostheses (post-amputation) | Covered — see CPB 0399 | S48.011–S68.729 | Separate Aetna coverage policy governs prosthetic devices; different billing pathway |
Aetna Hand Transplantation Billing Guidelines and Action Items 2025
These are not hypothetical steps. If you have Aetna patients scheduled for any upper extremity reconstructive procedure, work through this list before December 4, 2025.
| # | Action Item |
|---|---|
| 1 | Audit your surgical schedule for any planned hand transplantation or multi-digit allotransplantation cases. Pull any case involving Aetna-covered patients where the surgeon is planning either procedure. Flag them immediately. The effective date of this policy is December 4, 2025, and claims submitted after that date for these procedures will be denied. |
| 2 | Do not submit prior authorization requests expecting a different outcome. Aetna's classification as experimental means prior auth will not change the coverage determination. Spending staff time on a prior auth for hand transplantation billing wastes resources and delays patient financial counseling. Redirect that effort to patient notification. |
| 3 | Initiate financial counseling and get a signed patient acknowledgment before surgery. The patient needs to understand in writing that Aetna considers this procedure experimental and will not provide reimbursement. Document this conversation in the chart. Your compliance officer can help you structure the acknowledgment language correctly — loop them in if you're unsure. |
| 4 | Code diagnosis accurately using ICD-10-CM codes from the S48, S58, and S68 ranges. Traumatic amputation of the shoulder and upper arm (S48.011–S48.929), elbow and forearm (S58.011–S58.929), and wrist, hand, and fingers (S68.011–S68.729) are the relevant diagnosis code ranges under CPB 0816. These codes are not blocked — the diagnosis coding is valid. The procedure is what Aetna won't cover. |
| 5 | Route post-amputation patients toward CPB 0399 for prosthetic options. If the patient's clinical path leads to an upper limb prosthesis rather than transplantation, that's a covered track under a separate Aetna coverage policy. Make sure your team knows both policies and flags the correct one depending on the treatment plan. |
| 6 | Review any pending appeals on hand transplantation or multi-digit allotransplantation claims. If you have open appeals on these procedures, understand that CPB 0816 now has a December 4, 2025 effective date attached to this version. Any appeal argument built on coverage ambiguity is weaker than it was before. Talk to your billing consultant about whether continuing an appeal is worth the resources. |
| 7 | If you work in a transplant program that performs vascularized composite allotransplantation (VCA), consult your compliance officer about the broader regulatory and payer environment. Hand transplantation sits at the intersection of transplant medicine, reconstructive surgery, and experimental procedure coverage policy. The financial exposure on these cases is high. Get expert eyes on your billing protocols now. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Hand Transplantation Under CPB 0816
The policy data for CPB 0816 does not list specific CPT or HCPCS procedure codes. Aetna's classification of hand transplantation and multi-digit allotransplantation as experimental applies at the procedure level, not tied to specific CPT billing codes in this bulletin.
If your team is building a charge capture or denial tracking workflow for these procedures, work with your billing consultant to identify the relevant CPT codes your surgeons use. Do not assume a specific CPT code is covered because it isn't explicitly listed here as excluded — the policy language covers the procedures categorically.
Key ICD-10-CM Diagnosis Codes Under CPB 0816
These are the diagnosis code ranges Aetna lists under this policy. Use them accurately when coding upper extremity amputation cases.
| Code Range | Description |
|---|---|
| S48.011–S48.929 | Traumatic amputation of shoulder and upper arm |
| S58.011–S58.929 | Traumatic amputation of elbow and forearm |
| S68.011–S68.729 | Traumatic amputation of wrist, hand, and fingers |
The 7th character extensions on these codes specify laterality, type of amputation (complete vs. partial), and encounter type. Make sure your coders are applying the correct extensions — incomplete coding in these ranges is a common source of claim complications, even when the underlying procedure is separately adjudicated.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.